Jan‐Jong Hung
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
Papers in ⓘ
-
- Ubiquitin and proteasome pathways 19
- RNA Research and Splicing 10
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 9
- Heat shock proteins research 8
- Histone Deacetylase Inhibitors Research 6
- Cancer-related gene regulation 6
- Oncology 18
- Cancer-related Molecular Pathways 8
- Co-authors
- Wen‐Chang Chang (27 shared papers)Jian‐Ying Chuang (14 shared papers)Tsung‐I Hsu (19 shared papers)Yi-Ting Wang (5 shared papers)Ming-Jer Young (11 shared papers)Wen Chang (2 shared papers)Wu‐Chou Su (13 shared papers)Wen‐Bin Yang (10 shared papers)
- Journals
- The FASEB Journal (5 papers)Journal of Biomedical Science (5 papers)Oncogene (5 papers)Oncotarget (4 papers)Scientific Reports (3 papers)
- Partner nations
- TaiwanUnited StatesIndia
In The Last Decade
Jan‐Jong Hung
70 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 587
- Molecular Biology 1.9k
- Oncology 590
- Biological Psychiatry 37
- Immunology 253
Countries citing papers authored by Jan‐Jong Hung
This map shows the geographic impact of Jan‐Jong Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Jong Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Jong Hung more than expected).
Fields of papers citing papers by Jan‐Jong Hung
This network shows the impact of papers produced by Jan‐Jong Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Jong Hung. The network helps show where Jan‐Jong Hung may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan‐Jong Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 191 | |
| 2 | 2009 | 182 | |
| 3 | 2011 | 121 | |
| 4 | 2019 | 118 | |
| 5 | 2006 | 117 | |
| 6 | 2009 | 115 | |
| 7 | 2008 | 102 | |
| 8 | 2015 | 98 | |
| 9 | 1998 | 94 | |
| 10 | 2018 | 89 | |
| 11 | 2010 | 83 | |
| 12 | 2002 | 82 | |
| 13 | 2012 | 81 | |
| 14 | 2014 | 69 | |
| 15 | 2008 | 68 | |
| 16 | 2009 | 64 | |
| 17 | 2012 | 64 | |
| 18 | 2010 | 61 | |
| 19 | 2017 | 61 | |
| 20 | 2011 | 60 |
About Jan‐Jong Hung
Jan‐Jong Hung is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (19 papers), RNA Research and Splicing (10 papers), RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related Molecular Pathways (8 papers), Heat shock proteins research (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Cancer Research (587 citations), Molecular Biology (1.9k citations), Oncology (590 citations), Biological Psychiatry (37 citations) and Immunology (253 citations). Jan‐Jong Hung has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Wen‐Chang Chang, Jian‐Ying Chuang, Tsung‐I Hsu, Yi-Ting Wang, Ming-Jer Young, Wen Chang, Wu‐Chou Su, Wen‐Bin Yang, Shao‐An Wang and Meng-Ti Hsieh. Their work appears in journals such as The FASEB Journal, Journal of Biomedical Science, Oncogene, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.